suMMARY Penicillin concentrations in cerebrospinal fluid (CSF) were measured in 40 asymptomatic patients with syphilis, 10 of whom had neurosyphilis. The patients were treated with 2.4 MIU procaine penicillin a day intramuscularly in combination with 500 mg probenecid every six hours orally.
The therapeutic approach to neurosyphilis is controversial. Optimum treatment necessitates maintaining continuous treponemicidal penicillin concentrations for a sufficient length of time. It is not clear, however, whether the treponemicidal penicillin concentration of > 0018 mg/I recommended by the World Health Organisation is always needed. Current intramuscular penicillin regimens, which do not consistently give treponemicidal cerebrospinal fluid (CSF) penicillin concentrations, appear to be adequate for treating early syphilis, but may be insufficient for late (latent) syphilis. ' An intramuscular treatment regimen plus oral probenecid, which appeared to produce consistently treponemicidal penicillin concentrations, has been reported. 4 We report less favourable results from the same regimen.
Patients and methods
Forty asymptomatic patients with positive syphilis serology test results of unknown duration (for more than a year, with the possible exception of three patients) were admitted to hospital for lumbar puncture and initial treatment. All had positive results to the Treponema pallidum haemagglutination assay (TPHA) and the fluorescent treponemal antibody absorption (FTA-ABS) test. They received 2.4 MIU procaine penicillin a day intramuscularly for 10 days in combination with probenecid 500 mg orally every six hours (their mean (SD) weight was 70.7 calibration curve was made using horse serum. The lowest CSF concentration detected was 0-001 mg/I. In 30 patients the penicillin concentration in the CSF from the first collecting tube was compared with that in the fifth tube to assess the differences in concentrations at different levels of the central nervous system.
Results
The Our data do not favour using this intramuscular penicillin regimen to treat patients with asymptomatic neurosyphilis. Uncertain patient compliance with oral medication and the lack of data on the effect of probenecid on brain parenchyma penicillin concentrations further strengthen this view. 9 An alternative treatment policy for patients with early and late syphilis without neurological symptoms consists of 7.2 MIU benzathine penicillin G intramuscularly in weekly doses of 2-4 MIU, preferably followed by lumbar puncture one or two years later. Patients with symptomatic neurosyphilis, and possibly also patients with relevant persisting residual CSF abnormalities after intramuscular treatment, should be treated with intravenous penicillin.`'°A treatment regimen of 0.15 MIU per kilogram of body weight given in six equal doses a day for 15 days could be used.'2 It cannot be excluded that a smaller percentage of patients with syphilis but without neurological symptoms might develop (a)symptomatic neurosyphilis in the follow up period if treated with the intramuscular treatment regimen used in our study rather than the alternative intramuscular regimen mentioned. The risk of developing symptomatic neurosyphilis after intramuscular penicillin treatment appears to be small, however, if treatment is of sufficient duration, even if the regimen used does not give treponemicidal CSF penicillin concentrations. '3 
